Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Ernexa Therapeutics Inc. (ERNA) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
-- |
|
$-5.51M |
|
-- |
|
-- |
|
$5.59M |
|
$-5.59M |
|
$0.04M |
|
$-5.55M |
|
$-5.55M |
|
$-5.51M |
|
$-5.51M |
|
$-5.51M |
|
$-5.51M |
|
$-5.59M |
|
$-3.46M |
|
0.79M |
|
0.79M |
|
$-6.95 |
|
$-6.95 |
|
| Balance Sheet Financials | |
$10.00M |
|
$0.09M |
|
$0.55M |
|
$10.54M |
|
$3.46M |
|
-- |
|
$0.23M |
|
$3.68M |
|
$6.86M |
|
$6.86M |
|
$6.86M |
|
1.17M |
|
| Cash Flow Statement Financials | |
$-2.26M |
|
$-0.00M |
|
$9.56M |
|
$1.88M |
|
$9.18M |
|
$7.29M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.89 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-80.29% |
|
-80.27% |
|
-52.22% |
|
-80.27% |
|
$5.88 |
|
$-2.86 |
|
$-2.86 |
|